Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-31

Clinical Trial Update: Neuropsychologic and Immunological Evaluation in Treatment of Thyroid Diseases. Is Selenium Efficient? [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing whether selenium supplementation improves quality of life and neuropsychologic/immunologic outcomes in Graves' disease patients has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)

Snippet

Sponsor: Karolinska Institutet | Conditions: QoL Before and After 9 Month of Medical Treatment of Graves´Thyrotoxicosis, Potential Effect of Selenium | Phase 2 | Status: COMPLETED